New Analysis Shows Hospital Readmissions More Than Double Medicare Episode Payments

Better use of home health has potential to reduce rehospitalization rates across all episode types Prnewswire.com: 7/23/12. WASHINGTON, July 23, 2012 /PRNewswire-USNewswire/ — A comprehensive analysis of Medicare claims data demonstrates that Medicare payments more than double when the beneficiary’s care includes at least one hospital visit. The Alliance for Home Health Quality and Innovation (the Alliance) today […]

HHS announces $275M state funding initiative

Healthcarefinancenews.com: July 23, 2012 | Erin McCann, Contributing Editor WASHINGTON – The U.S. Department of Health and Human Services (HHS) is making available up to $275 million to states to help them develop and test improvements to their healthcare systems that would bolster healthcare quality and reduce expenditures. The State Innovation Models initiative, which is made […]

Hospitals' Readmissions Rates Not Budging

Kaiserhealthnews.org: By Jordan Rau, KHN Staff Writer, JUL 19, 2012 This story was produced in collaboration with  The nation’s hospitals are making little headway in reducing the frequency at which patients are readmitted despite a campaign by the government and the threat of financial penalties, according to Medicare data released Thursday. The government and health policy experts consider frequent […]

Medicare Beneficiaries Less Likely To Experience Cost- And Access-Related Problems Than Adults With Private Coverage

Content.healthaffairs.org: 7/18/12. The experiences of people covered by Medicare and those with private employer insurance can help inform policy debates over the federal budget deficit, Medicare’s affordability, and the expansion of private health insurance under the Affordable Care Act. This article provides evidence that people with employer-sponsored coverage were more likely than Medicare beneficiaries to forgo […]

Poorer hospitals may suffer from Medicare changes

Reuters.com: By Genevra Pittman, NEW YORK | Mon Jul 16, 2012 4:40pm EDT Under upcoming changes in Medicare and Medicaid payment policies, hospitals largely treating the poor and uninsured may be hit extra hard if patients continue to rate their experiences there lower than at other hospitals, according to a new study. So-called safety-net hospitals take in a lot […]

Innovation and crowdsourcing in clinical trials: Interview with Dr Tomasz Sablinski

Pharmaphorum.com: 7/24/12. Angela Dunn interviews Dr Tomasz Sablinski Angela Dunn interviews Dr Tomasz Sablinski, the Founder and CEO of Transparency Life Sciences, the world’s first drug development company based on Open Innovation (OI). According to the “2012 State of Global Open Innovation“, Forrester defines Open Innovation (OI) as: “Innovation efforts that leverage external partners, ideas, […]

Global E-Clinical Trial Technologies Market to Reach US$1.37 Billion by 2018, According to New Report by Global Industry Analysts, Inc.

San Jose, California (PRWEB) July 23, 2012 Due to narrowing drug pipelines, expiring patents of popular drugs, and a scarcity of prospective drug launches, the pharmaceutical industry is actively seeking tools that can quicken the drug discovery procedure and boost productivity. Though ongoing research is predicted to help detect additional drug candidates, the rise in […]

Two Centuries of Assessing Drug Risks

N Engl J Med 2012;  Jerry Avorn, M.D.July 19, 2012 The history of medicine is largely the story of medicines — a continuing tale of unfolding risks and benefits. Yet the medical world into which the Journal was born in 1812 did not systematically assess the side effects of treatments in relation to the good they did. […]

Proposal for a Clinical Trials Regulation – Questions and answers

Europa.eu: July 17, 2012 What are clinical trials? Clinical trials are a vital step in the development of new and safe medicines and in improving medical treatment. Human volunteers are enrolled in a clinical trial for the following reasons: to test the safety and effectiveness of new medicines, to test new indications for existing medicines or […]

Population survival from childhood cancer in Britain during 1978–2005 by eras of entry to clinical trials

Annonc.oxfordjournals.org: 7/17/12. Inclusion in clinical trials is generally viewed as best practice for most newly diagnosed childhood cancers, but the impact on population-based survival has rarely been examined. Patients and methods The population-based data were analysed for 25 853 children (66% of all registered childhood cancers) diagnosed in Britain during 1978–2005 with acute lymphoblastic leukaemia (ALL), acute myeloid […]

© 2024 National Health Index, LLC. All Rights Reserved.